Revenue
2023
2024
2025
Exousia Bio, Inc. (LMMY)
Price$0.0206Cached quote
Net income
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $3,750 | $11,500 | $0 |
| Gross profit | −$3,501 | $1,833 | $0 |
| Gross margin | −93.36% | 15.94% | — |
| Operating expenses | $31,843 | $28,076 | $56,421 |
| Operating income | — | −$26,243 | −$56,421 |
| Operating margin | — | −228.20% | — |
| EBITDA | — | −$11,543 | −$51,388 |
| EBITDA margin | — | −100.37% | — |
| Net income | $51,395 | −$25,807 | −$56,421 |
| Net profit margin | 1,370.53% | −224.41% | — |
| Basic EPSper basic share | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | $0.00 | $0.00 | $0.00 |
Owners
Reported shareholders